These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37309108)

  • 1. Dosing practices made mundane: Enacting HIV pre-exposure prophylaxis adherence in domestic routines.
    Smith AKJ; Lancaster K; Rhodes T; Holt M
    Sociol Health Illn; 2023 Nov; 45(8):1747-1764. PubMed ID: 37309108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol-antiretroviral interactive toxicity beliefs as a potential barrier to HIV pre-exposure prophylaxis among men who have sex with men.
    Kalichman SC; Eaton L
    J Int AIDS Soc; 2017 Jul; 20(1):21534. PubMed ID: 28715159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing determinants of pre-exposure prophylaxis (PrEP) adherence among a sample of rural Midwestern men who have sex with men (MSM).
    Owens C; Hubach RD; Lester JN; Williams D; Voorheis E; Reece M; Dodge B
    AIDS Care; 2020 Dec; 32(12):1581-1588. PubMed ID: 32338061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada.
    Newman PA; Guta A; Lacombe-Duncan A; Tepjan S
    J Int AIDS Soc; 2018 Nov; 21(11):e25211. PubMed ID: 30474351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing as affective clinical practice: Transformations in sexual health consultations through HIV pre-exposure prophylaxis.
    Smith AKJ; Newman CE; Haire B; Holt M
    Sociol Health Illn; 2022 Jul; 44(7):1182-1200. PubMed ID: 35635513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study.
    Franks J; Hirsch-Moverman Y; Loquere AS; Amico KR; Grant RM; Dye BJ; Rivera Y; Gamboa R; Mannheimer SB
    AIDS Behav; 2018 Apr; 22(4):1139-1149. PubMed ID: 29143163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia.
    Chan C; Vaccher S; Fraser D; Grulich AE; Holt M; Zablotska-Manos I; Prestage GP; Bavinton BR
    AIDS Behav; 2022 Jan; 26(1):88-95. PubMed ID: 34142274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
    Molina JM; Ghosn J; Assoumou L; Delaugerre C; Algarte-Genin M; Pialoux G; Katlama C; Slama L; Liegeon G; Beniguel L; Ohayon M; Mouhim H; Goldwirt L; Spire B; Loze B; Surgers L; Pavie J; Lourenco J; Ben-Mechlia M; Le Mestre S; Rojas-Castro D; Costagliola D;
    Lancet HIV; 2022 Aug; 9(8):e554-e562. PubMed ID: 35772417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving HIV pre-exposure prophylaxis (PrEP) adherence and retention in care: Process evaluation and recommendation development from a nationally implemented PrEP programme.
    MacDonald J; Estcourt CS; Flowers P; Nandwani R; Frankis J; Young I; Clutterbuck D; Dalrymple J; McDaid L; Steedman N; Saunders J
    PLoS One; 2023; 18(10):e0292289. PubMed ID: 37812636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imperfect adherence in real life: a prevention-effective perspective on adherence to daily and event-driven HIV pre-exposure prophylaxis among men who have sex with men - a prospective cohort study in Taiwan.
    Wu HJ; Wen-Wei Ku S; Chang HH; Li CW; Ko NY; Strong C
    J Int AIDS Soc; 2021 May; 24(5):e25733. PubMed ID: 34018330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can We Predict Incorrect PrEP Use in High HIV Risk Situations Among Men Who Have Sex With Men? An Analysis of Be-PrEP-ared, the Belgian PrEP Demonstration Study.
    Vuylsteke B; Reyniers T; Nöstlinger C; Smekens T; Kenyon C; Laga M
    J Acquir Immune Defic Syndr; 2021 Sep; 88(1):36-44. PubMed ID: 34081665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-exposure Prophylaxis Use and Medication Adherence Among Men Who Have Sex With Men: A Systematic Review of the Literature.
    Maxwell S; Gafos M; Shahmanesh M
    J Assoc Nurses AIDS Care; 2019; 30(4):e38-e61. PubMed ID: 31241514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions and Practicalities Influencing Pre-exposure Prophylaxis Adherence Among Men Who Have Sex with Men in England.
    Arnold-Forster D; Horne R; Nutland W; Wayal S; Rayment M; Rae C; Desai M; Clarke A; Sullivan A; McCormack S; Gafos M
    AIDS Behav; 2022 Aug; 26(8):2768-2782. PubMed ID: 35182281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-exposure prophylaxis (PrEP) uptake and adherence experiences of gay and bisexual men who engage in chemsex: A qualitative study.
    Maxwell S; Shahmanesh M; Gafos M
    Int J Drug Policy; 2022 May; 103():103630. PubMed ID: 35231668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitators and barriers of 2-1-1 HIV pre-exposure prophylaxis.
    Camp C; Saberi P
    PLoS One; 2021; 16(5):e0251917. PubMed ID: 34014998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated with Preferred Pre-Exposure Prophylaxis Dosing Regimen Among Men Who Have Sex with Men in Real-World Settings: A Mixed-Effect Model Analysis.
    Wu HJ; Ku SW; Li CW; Ko NY; Yu T; Chung AC; Strong C
    AIDS Behav; 2021 Jan; 25(1):249-258. PubMed ID: 32643021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gay and Bisexual Men's Strategies to Maintain Daily Adherence to Their HIV Pre-exposure Prophylaxis (PrEP) Medication: Results from a Qualitative Study.
    Grov C; Flynn AWP; D'Angelo AB; Lopez-Rios J; Pantalone DW; Holloway IW; Parsons JT
    Prev Sci; 2019 Jan; 20(1):168-177. PubMed ID: 30637602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
    J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.
    Mutua G; Sanders E; Mugo P; Anzala O; Haberer JE; Bangsberg D; Barin B; Rooney JF; Mark D; Chetty P; Fast P; Priddy FH
    PLoS One; 2012; 7(4):e33103. PubMed ID: 22511916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.